Detalles de la búsqueda
1.
Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial).
Clin Exp Allergy;
52(3): 405-415, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34854157
2.
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Br J Dermatol;
185(1): 139-146, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393074
3.
An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).
Br J Dermatol;
184(5): 840-848, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32920824
4.
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
Br J Dermatol;
184(5): 828-839, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33006767
5.
Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in England.
BMC Med Res Methodol;
21(1): 22, 2021 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541270
6.
Scoping the international impact from four independent national dermatology trials.
Clin Exp Dermatol;
46(4): 657-662, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179251
7.
Measurement properties of patient-reported outcome measures for eczema control: a systematic review.
J Eur Acad Dermatol Venereol;
35(10): 1987-1993, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33977561
8.
Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP).
Br J Dermatol;
183(3): 524-536, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31794074
9.
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Br J Dermatol;
2020 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179283
10.
Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczema.
J Eur Acad Dermatol Venereol;
33(6): 1124-1132, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30720903
11.
How should minimally important change scores for the Patient-Oriented Eczema Measure be interpreted? A validation using varied methods.
Br J Dermatol;
178(5): 1135-1142, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29355894
12.
Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.
Br J Dermatol;
178(2): 415-423, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28940316
13.
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
Br J Dermatol;
178(5): e332-e341, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29672835
14.
Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.
Allergy;
72(1): 146-163, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27322918
15.
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
Br J Dermatol;
176(4): 979-984, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27858989
16.
Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review.
Allergy;
71(3): 358-70, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26564008
17.
Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review.
Br J Dermatol;
175(4): 678-86, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27012805
18.
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
Br J Dermatol;
175(1): 69-79, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27436240
19.
How to teleconference effectively.
Br J Dermatol;
173(3): 806-10, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26404576
20.
Assessing uptake of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set and recommended instruments.
Br J Dermatol;
183(3): 566-568, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32167583